How to Track FDA Approval Risk Before a PDUFA Date
Learn a practical way to monitor FDA approval risk before a PDUFA date by watching evidence, labeling, safety, manufacturing, and company updates.
FDA's Real-Time Trial Data and AI Plan Could Change Biotech Timelines
FDA wants to use real-time data and AI to speed up clinical trials. Here is what the proposal could mean for biotech timelines, capital efficiency, and investors.
How to Recognize Regulatory Language in Biotech News
Learn how to recognize regulatory language in biotech news, including filing, review, approval, and delay terminology.
How to Tell If an FDA Update Is Important
Learn how to judge whether an FDA-related biotech update is important enough to matter for stock movement and catalyst tracking.
What Is a Monoclonal Antibody?
Learn what a monoclonal antibody is, why it matters in biotech, and how antibody drugs shape development, approval, and market competition.
What Is Label Expansion in Biotech?
Learn what label expansion means in biotech, why it matters for commercial growth, and how new indications can extend a product's life.
What Is a Biosimilar and Why Does It Matter for Biotech Investors?
Learn what a biosimilar is, why it matters for biologic competition, and how biosimilar news can affect original drug markets.
What Is a Surrogate Endpoint?
Learn what a surrogate endpoint is, why it matters in biotech, and how it supports faster regulatory decisions and accelerated approval.
What Is a Post-Marketing Study?
Learn what post-marketing studies are, why the FDA requires them, and how they affect biotech news after approval.
What Is Accelerated Approval?
Learn what accelerated approval means in biotech, why it matters for serious diseases, and how it depends on surrogate endpoints and post-marketing studies.
What Is Priority Review and Why Does It Matter?
Learn what priority review means at the FDA, why it matters for biotech approval timelines, and how it can shorten a review cycle.
What Is Fast Track Designation?
Learn what fast track designation means in biotech, why it matters for serious diseases, and how it can support a quicker development path.
What Is Breakthrough Therapy Designation?
Learn what breakthrough therapy designation means, why it matters in biotech, and how it can speed development and regulatory interaction.
What Is Orphan Drug Designation and Why Does It Matter?
Learn what orphan drug designation means, why it matters for rare disease biotech programs, and how it affects development and commercialization.
What Is an IND and Why Does It Matter in Drug Development?
Learn what an IND is, why it matters in biotech drug development, and how it signals the beginning of human clinical testing.
Why Biotech Is Especially Well-Suited to Event-Driven Information Products
Learn why biotech is naturally suited to event-driven news products, and why catalysts, timelines, and regulatory milestones create strong product value.
What Does "Catalyst" Mean in Biotech News?
Learn what a catalyst means in biotech news, why catalyst events move stocks, and how investors use catalyst alerts to track trials and FDA milestones.
What Is a Catalyst Window? Why Timing Matters in Biotech Alerts
Learn what a catalyst window is, why timing matters in biotech news, and how investors use windows to monitor trial, FDA, and earnings events.
What Is a CRL? Why One FDA Rejection Letter Can Change a Company's Trajectory
Learn what a CRL is, why the FDA issues Complete Response Letters, and how a CRL can affect biotech stocks, timelines, financing, and pipeline strategy.
What Does PDUFA Mean? A Practical Guide to a Key FDA Approval Milestone
Understand what PDUFA means, how a PDUFA date works, and why this FDA milestone is one of the most important events in biotech news and investing.
What Is a Biotech Catalyst? Why It Matters in Biotech News
Learn what a biotech catalyst is, why catalyst-driven news moves biotech stocks, and how investors use catalyst alerts to follow FDA and clinical events.